Technical Analysis for ACUR - Acura Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 0.54 -1.82% -0.01
ACUR closed down 1.82 percent on Friday, June 23, 2017, on 46 percent of normal volume. It was able to find support at its 50 day moving average. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ACUR trend table...

Date Alert Name Type % Chg
Jun 23 50 DMA Support Bullish 0.00%
Jun 23 Hammer Candlestick Bullish 0.00%
Jun 23 Stochastic Reached Overbought Other 0.00%
Jun 23 Bollinger Band Squeeze Range Contraction 0.00%
Jun 22 Crossed Above 50 DMA Bullish -1.82%

Older signals for ACUR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies. Its products include Oxecta Tablets CII, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed, an over-the-counter immediate-release pseudoephedrine HCl tablet that is used as a nasal decongestant in various non-prescription and prescription cold, sinus, and allergy products. The company has seven additional opioid products utilizing Aversion technology in various stages of development. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc., a wholly-owned subsidiary of Pfizer Inc. to develop and commercialize certain opioid analgesic products utilizing the company's proprietary Aversion technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.
Is ACUR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.18
52 Week Low 0.401
Average Volume 13,672
200-Day Moving Average 0.8214
50-Day Moving Average 0.5249
20-Day Moving Average 0.5169
10-Day Moving Average 0.5264
Average True Range 0.0368
ADX 16.57
+DI 15.69
-DI: 15.69
Chandelier Exit (Long, 3 ATRs) 0.4496
Chandelier Exit (Short, 3 ATRs) 0.5604
Upper Bollinger Band 0.5508
Lower Bollinger Band 0.483
Percent B (%b) 0.84
Bandwidth 0.131167
MACD Line 0.0035
MACD Signal Line -0.0005
MACD Histogram 0.004